[{"address1": "6005 Hidden Valley Road", "address2": "Suite 110", "city": "Carlsbad", "state": "CA", "zip": "92011", "country": "United States", "phone": "858 293 4900", "website": "https://www.designtx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.", "fullTimeEmployees": 54, "companyOfficers": [{"maxAge": 1, "name": "Mr. Pratik  Shah Ph.D.", "age": 54, "title": "Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 704100, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sean  Jeffries Ph.D.", "age": 44, "title": "Chief Operating Officer", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 554013, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Aseem Z. Ansari Ph.D.", "title": "Co-Founder & Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Julie D. Burgess CPA", "title": "Chief Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mustapha  Parekh", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Dawn  Giangiulio", "title": "Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.42, "open": 4.36, "dayLow": 4.085, "dayHigh": 4.415, "regularMarketPreviousClose": 4.42, "regularMarketOpen": 4.36, "regularMarketDayLow": 4.085, "regularMarketDayHigh": 4.415, "beta": 1.833, "forwardPE": -3.535724, "volume": 198956, "regularMarketVolume": 198956, "averageVolume": 181051, "averageVolume10days": 90020, "averageDailyVolume10Day": 90020, "bid": 4.21, "ask": 4.34, "bidSize": 100, "askSize": 100, "marketCap": 242904080, "fiftyTwoWeekLow": 2.245, "fiftyTwoWeekHigh": 7.77, "fiftyDayAverage": 5.63, "twoHundredDayAverage": 4.905775, "currency": "USD", "enterpriseValue": -1287016, "floatShares": 25236562, "sharesOutstanding": 56621000, "sharesShort": 3101499, "sharesShortPriorMonth": 2698771, "sharesShortPreviousMonthDate": 1734048000, "dateShortInterest": 1736899200, "sharesPercentSharesOut": 0.0548, "heldPercentInsiders": 0.36446998, "heldPercentInstitutions": 0.56483, "shortRatio": 14.25, "shortPercentOfFloat": 0.121300004, "impliedSharesOutstanding": 56621000, "bookValue": 4.459, "priceToBook": 0.9620991, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -47779000, "trailingEps": -0.85, "forwardEps": -1.21, "enterpriseToEbitda": 0.021, "52WeekChange": 0.90517247, "SandP52WeekChange": 0.21027291, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "DSGN", "underlyingSymbol": "DSGN", "shortName": "Design Therapeutics, Inc.", "longName": "Design Therapeutics, Inc.", "firstTradeDateEpochUtc": 1617024600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "334bfad0-1826-3cb5-ba7e-3a834e43b6bd", "messageBoardId": "finmb_625814292", "gmtOffSetMilliseconds": -18000000, "currentPrice": 4.29, "targetHighPrice": 12.0, "targetLowPrice": 4.0, "targetMeanPrice": 7.0, "targetMedianPrice": 5.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 254074000, "totalCashPerShare": 4.487, "ebitda": -60225000, "totalDebt": 2522000, "quickRatio": 34.345, "currentRatio": 34.613, "debtToEquity": 0.999, "returnOnAssets": -0.13537, "returnOnEquity": -0.17781, "grossProfits": -43205000, "freeCashflow": -30067250, "operatingCashflow": -46043000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-08"}]